<DOC>
	<DOCNO>NCT00689338</DOCNO>
	<brief_summary>To evaluate efficacy safety anidulafungin treatment systemic fungal infection intensive care critical care unit patient .</brief_summary>
	<brief_title>Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study</brief_title>
	<detailed_description />
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidemia</mesh_term>
	<mesh_term>Candidiasis , Invasive</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<mesh_term>Anidulafungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>ICU patient diagnosis document candidemia invasive candidiasis belong one follow specific population : Postabdominal surgery . Elderly &gt; 65 year old . Renal insufficiency / failure / hemodialysis . Solid tumor . Solidorgan ( liver , kidney , lung , heart ) transplant recipient . Hepatic insufficiency . Neutropenic include hematology oncology patient . Patients poor venous access would preclude IV drug delivery multiple blood draw .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Candida</keyword>
	<keyword>Candidemia</keyword>
	<keyword>Systemic Candidiasis</keyword>
	<keyword>ICU</keyword>
	<keyword>Intensive Care Unit</keyword>
	<keyword>Critical Care Unit</keyword>
	<keyword>Anidulafungin</keyword>
	<keyword>Ecalta</keyword>
	<keyword>Eraxis</keyword>
	<keyword>Fluconazole</keyword>
	<keyword>Voriconazole</keyword>
</DOC>